Aclaris Therapeutics, Inc. Share Price

Aclaris Therapeutics, Inc. Share Price

NASDAQ: ACRS | Small Cap
$3.96
-$0.04 (-1%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Aclaris Therapeutics, Inc. Stock Performance

Open
$3.98
Prev. Close
$4.00
Circuit Range
N/A
Day Range
$3.88 - $4.07
Year Range
$2.12 - $6.59
Volume
1,40,805
Average Traded
$3.97

Aclaris Therapeutics, Inc. Share Price Today

As of 31 October 2026, Aclaris Therapeutics, Inc.'s share price is $3.96. The stock opened at $3.98, compared to its previous close of $4.00. During today's trading session, Aclaris Therapeutics, Inc.'s share price traded between $3.88 and $4.07, with an average price of $3.98. Over the past 52 weeks, the stock has recorded a high of $6.59 and a low of $2.12. In terms of performance, Aclaris Therapeutics, Inc.'s share price has declined by 8.76% over the last six months and is up 57.14% on a year-on-year basis.

Aclaris Therapeutics, Inc. Share Price Chart

Line chart of the Aclaris Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 3.89 to 4.03, ending at 3.96.
$3.88$4.07
L
Show Current Price
H

Aclaris Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$485.36M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.51
Revenue (TTM)
$7.83B
Return On Equity (TTM)
-60.79%
Profit Margin
-829.12%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-47.23%

Aclaris Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$3.30$1.30$2.00$1.63
Net Profit-$14.61-$19.80-$19.82-$21.51
Net Profit Margin-442.73%-1523.08%-991.00%-1319.63%
Income ChangeN/A-35.52%-0.10%-8.53%

Aclaris Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$29.75$31.25$18.72$7.83
Net Profit-$86.91-$88.48-$132.07-$64.92
Net Profit Margin-292.13%-283.14%-705.50%-829.12%
Income ChangeN/A-1.81%-49.27%50.84%

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.

Aclaris Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$5.17
$3.98
-24.57%
Sep 2026
$6.15
$5.27
-14.31%
Aug 2026
$5.12
$6.15
+18.38%
Jul 2026
$5.61
$5.20
-1.89%
Jun 2026
$4.52
$5.29
+16.25%
May 2026
$4.32
$4.55
+4.95%
Apr 2026
$3.82
$4.34
+15.73%
Mar 2026
$2.79
$3.75
+30.66%
Feb 2026
$3.44
$2.87
-18.23%
Jan 2026
$2.99
$3.51
+17.00%
Dec 2025
$2.76
$3.00
+6.19%
Nov 2025
$2.63
$2.83
+12.10%

ACRS Share Price FAQs